Metraipolis › archive › dc_1eb010d76e3d

Prognostic Value of the Lung Immune Prognostic Index in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab: A Real-World Analysis Beyond PD-L1… — Europe PMC PMID:42793675

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42793675
DOI
10.3390/diagnostics16182890
License (as archived)
solo-consultazione
Archived
2026-10-15T21:36:14.959Z
SHA-256 of the archived text
b9ebfd076dcea7147a452749c4d4e06fd7154375cb1dad22edee7518ee45d27a
Stable URL of this page
https://metraipolis.com/documento/dc_1eb010d76e3d

How to cite

Prognostic Value of the Lung Immune Prognostic Index in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab: A Real-World Analysis Beyond PD-L1… — Europe PMC PMID:42793675 — Europe PMC (en), https://europepmc.org/article/MED/42793675 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1eb010d76e3d (Metraipolis archive dc_1eb010d76e3d, sha256 b9ebfd076dcea7147a452749c4d4e06fd7154375cb1dad22edee7518ee45d27a)
BibTeX
@misc{dc1eb010d76e3d,
  title = {Prognostic Value of the Lung Immune Prognostic Index in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab: A Real-World Analysis Beyond PD-L1… — Europe PMC PMID:42793675},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42793675},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1eb010d76e3d; sha256 b9ebfd076dcea7147a452749c4d4e06fd7154375cb1dad22edee7518ee45d27a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42793675. Agents can read the archived copy with the MCP tool read_document.